The physiology of obesity

October 9, 2020
Ted Kyle
Volume 97, Issue 14

What are the implications for primary care?

Twenty-two years ago, the National Institutes of Health published the first ever evidence-based guidelines for identification and treatment of obesity. This 262-page report was an important milestone, but at the time, the authors stated that the “understanding of how and why obesity develops is incomplete.” Today, we know much more. And because of that knowledge, obesity care has changed radically in twenty years.

Today we know that obesity is an altered physiologic state.

The drivers of obesity

Obesity researchers know that obesity results from the effects of environmental triggers on genetically susceptible individuals. These triggers are many but may be grouped into four categories:

Alterations to the food supply are most cited – the composition of food, its quantity, and its promotion to consumers. Research has identified many dimensions of the food supply that may contribute.

A physical and technological environment that makes routine physical exertion less common.

Stress and distress in many forms can promote a state of obesity.

Finally, drugs and chemicals can act as endocrine disruptors with the effect of promoting obesity.

Implications for primary care

Perhaps the most important change in understanding the physiology of obesity comes from a 2011 study in the New England Journal of Medicine. Sumithran et al. demonstrated that weight loss causes changes in metabolic hormones that serve to return the body to its prior level of adiposity. Simply stated, the authors documented how the body acts to protect fat mass in subjects with overweight or obesity.

In other words, they documented that the physiology of obesity makes weight loss, by itself, unlikely to be an effective treatment for the chronic disease of obesity. It requires chronic treatment —just like dyslipidemia, hypertension, or diabetes.

The meaning of these insights for primary care is straightforward. When obesity is a clinical concern, simply advising a patient to lose weight will have a negligible benefit. The physiology of this disease state will make long-term clinical improvement very unlikely – even though many patients might lose weight in the short term.

The emerging standard of care is to use a range of treatments to help a patient reach and maintain a better state of health. These include dietary interventions, physical activity, behavioral therapy, pharmacotherapy, and metabolic surgery. Most often, a combination of these will yield the best outcomes, tailored to the needs of the patient.

A growing number of primary care physicians are seeking certification in obesity medicine to equip themselves to provide such treatment. Others might instead refer to an obesity medicine specialist. Either way, the patient will benefit from evidence-based care for this complex, chronic disease.

Ted Kyle is a pharmacist and health innovator living in Pittsburgh.

download issueDownload Issue : Medical Economics October 2020